| Case (reference) |
Age/Gender |
Cr (mg/dl)
[Ccr (mL/min)] |
UP (g/day)
[dipstick] |
Calcium |
ACE |
Therapy |
Final follow-up |
| 1. (14) |
44/F |
7.1 |
0 |
normal |
NA |
PSL 60/0 mg |
Cr 1.3 at 8 mo |
| 2. (15) |
48/M |
8.0 |
[+] |
normal |
normal |
PSL 60 mg |
Cr 4.0 at 1.5 mo |
| 3. (16) |
66/F |
4.3 |
1.2 |
NA |
NA |
PSL 20 mg |
Cr 1.9 at 15 mo |
| 4. (17) |
57/F |
4.95 |
0.5 |
normal |
high |
PSL 1 mg/kg |
Cr 2.3 at 89 mo |
| 5. (18) |
26/M |
5.3 |
0.36 |
NA |
NA |
PSL 30mg |
Cr 3.0 at 14 mo |
| 6. (19) |
48/F |
1.9 |
1.0 |
normal |
high |
PSL 60 mg |
Cr 1.0 at one mo |
| 7. (20) |
14/F |
5.13 |
0.4 |
normal |
NA |
PSL 40 mg |
CCr at 3 mo |
| 8. (11) |
F |
[5] |
NA |
normal |
|
HD+ |
Ccr 18 at 48 mo |
| 9. (11) |
M |
[2] |
NA |
normal |
|
HD+ |
Ccr 40 at 11 mo |
| 10. (11) |
48~71 F |
[6] |
NA |
normal |
high in one |
PSL 0.5-1 mg/kg |
Ccr 20 at 12 mo |
| 11. (11) |
M |
[19] |
NA |
normal |
|
|
Ccr 27 at 73 mo |
| 12. (11) |
M |
[20] |
NA |
normal |
|
|
Ccr 20 at 17 mo |
| 13. (21) |
71/F |
6.0 |
NA |
high |
high |
PSL 1 mg/kg |
Cr 2.1 at 6 mo |
| 14. (22) |
35/M |
4.5 |
< 0.5 |
normal |
normal |
PSL 60 mg |
HD at 15 mo |
| 15. (22) |
70/M |
4..0 |
0.8 |
high |
high |
PSL 30 mg |
Ccr 21 at 9 mo |
| 16. (22) |
69/F |
3.4 |
< 0.2 |
normal |
normal |
PSL 30 mg |
HD at 3 mo |
| 17. (22) |
64/F |
3.4 |
0.4 |
normal |
normal |
PSL 40 mg |
Ccr 55 at 48 mo |
| 18. (22) |
69/M |
5..6 |
0.2 |
normal |
high |
PSL 40 mg |
Ccr 29 at 3 mo |
| 19. (22) |
70/M |
14.2 |
0.9 |
NA |
normal |
HD + PSL 40 mg* |
Ccr 22 at 56 mo |
| 20. (22) |
72/M |
4.5 |
0 |
normal |
high |
PSL 20 mg |
Ccr 31 at 7 mo |
| 21. (23) |
41/F |
2.1 |
3.6 |
normal |
normal |
PSL 60 mg |
Cr 1.43 at 17 mo |
| 22. (24) |
80/M |
7.1 |
0.37 |
normal |
low |
PSL 60 mg + AZ |
Cr 3.5 at 8 mo |
| 23. (25) |
62/M |
2.42 |
1.1 |
high |
high |
PSL 20 mg |
Cr 1.5at 4 mo |
| 24. (26) |
13/M |
2.4 |
1.2 |
normal |
normal |
PSL 1 mg/kg* + IFX |
Cr 1.6 at 10 mo |
| 25. (27) |
15/M |
7.2 |
+ |
normal |
normal |
PSL 40 mg* + MMF |
Cr 1.1 at 21 mo |
| 26. (28) |
57/M |
2.9 |
1.4 |
normal |
high |
PSL 60 mg* + IFX |
Cr 1.8 at 17 mo |
| 27. (39) |
16/M |
1.34 |
0.46 |
normal |
normal |
PSL* + AZ, MMF |
Cr 1.06 at one mo |
| 28. (30) |
37/M |
5.42 |
0 |
high |
high |
PSL 40 mg |
Cr 0.97 at one mo |
| 29. (31) |
30/M |
2.2 |
0 |
high |
normal |
PSL 1 mg/kg |
Cr 1.3 at 6 mo |
| Current case |
64/M |
4.84 |
< 0.1 |
high |
high |
PSL 30 mg |
Cr 0.96 at 52 mo |
Ccr, creatinine clearance; Cr, creatinine; UP, urinary protein; ACE, angiotensin converting enzyme; PSL, prednisolone; IFX, infliximab; MMF, mycophenolate mofetil; AZ,
azathioprine; HD, hemodialysis; NA, not available; 60/0 mg, 60 mg every other day.
*Following methylprednisolone pulse therapy. The dose of prednisolone indicates that at initial therapy. |
